In line with the upcoming new Swiss legislation with respect to the registration and use of “Swiss” (“Switzerland”, etc) that will come into force on the 1st of January 2017, Nexgen Pharma Ltd will be embarking on a compliance adherence policy to educate customers on the use of “Swiss” for products, brands and labeling where pertinent.
A 6-month transition program will commence March 2016 to administer various processes to meet the required guidelines imposed.